Tender

BCU-CP-59436 - Detoxification Services

NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)

This public procurement record has 1 release in its history.

Tender

16 Sep 2025 at 00:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The NHS Wales Shared Services Partnership, hosted by Velindre University NHS Trust, has initiated an open procurement process to recommission inpatient substance misuse detoxification services in North Wales, under the title "BCU-CP-59436 - Detoxification Services". This tender falls within the health industry category and addresses a critical need for specialised care for individuals with substance dependencies. The procurement stage is currently at the tender phase, with a tender submission deadline set for midday on 7th October 2025. The service provision focuses on regions UKL11, UKL12, UKL13, and UKL23, highlighting areas with notable rates of substance misuse. The tender is valued at £5,100,000 and will utilise an electronic submission method through the eTender Wales portal.

This tender presents significant business growth opportunities, particularly for healthcare providers specialising in addiction services and inpatient care. Businesses with experience in delivering high-quality healthcare services and a strong understanding of managing co-morbid physical and psychiatric complications could find this tender well-suited to their capabilities. The procurement process will consider a balance of 30% cost and 70% quality, offering an incentive for businesses that prioritise service excellence. Furthermore, the procurement offers a potential contractual duration of three years, with the possibility of extending for two additional one-year periods, subject to supplier performance. Participation in this tender could enhance business credibility and expand service reach within the critical healthcare sector in Wales.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

BCU-CP-59436 - Detoxification Services

Notice Description

The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.

Lot Information

Lot 1

The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. Please see Information for Bidders document on the Bravo Solutions portal for further details. Betsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. The tender will be awarded based on 30% cost & 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered. The etenderwales bravosolution ref:Project: project_59436 and itt_120050 Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk.

Renewal: an option to extend for two (2) further one (1) year periods, at the discretion of the Health Board and subject to supplier performance.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-155749
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
OJEU - F2 - Contract Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85312500 - Rehabilitation services

Notice Value(s)

Tender Value
£5,100,000 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Sep 20255 months ago
Submission Deadline
7 Oct 2025Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
2028

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
Contact Name
Gethin Barlow
Contact Email
gethin.barlow@wales.nhs.uk
Contact Phone
+44 2921501500

Buyer Location

Locality
CARDIFF
Postcode
CF15 7QZ
Post Town
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL51 Central Valleys and Bridgend
Delivery Location
TLL11 Isle of Anglesey, TLL12 Gwynedd, TLL13 Conwy and Denbighshire, TLL23 Flintshire and Wrexham
Local Authority
Rhondda Cynon Taf
Electoral Ward
Taff's Well
Westminster Constituency
Cardiff North

Further Information

Notice Documents

  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=SEP544738
    BCU-CP-59436 - Detoxification Services - The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-kuma6s-155749-2025-09-16T00:00:00Z",
    "date": "2025-09-16T00:00:00Z",
    "ocid": "ocds-kuma6s-155749",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-1",
            "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)"
            },
            "address": {
                "streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw",
                "locality": "Cardiff",
                "region": "UKL",
                "postalCode": "CF15 7QZ"
            },
            "contactPoint": {
                "name": "Gethin Barlow",
                "email": "gethin.barlow@wales.nhs.uk",
                "telephone": "+44 2921501500",
                "url": "https://etenderwales.bravosolution.co.uk/web/login.shtml"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
            }
        },
        {
            "id": "org-2",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)",
        "id": "org-1"
    },
    "tender": {
        "id": "ocds-kuma6s-155749-tender-155749-BCU-CP-59436",
        "title": "BCU-CP-59436 - Detoxification Services",
        "description": "The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.",
        "status": "active",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "85312500",
                        "scheme": "CPV"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL11"
                    },
                    {
                        "region": "UKL12"
                    },
                    {
                        "region": "UKL13"
                    },
                    {
                        "region": "UKL23"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 5100000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "services",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://etenderwales.bravosolution.co.uk/web/login.shtml",
        "tenderPeriod": {
            "endDate": "2025-10-07T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2025-10-07T12:00:00Z"
        },
        "documents": [
            {
                "id": "SEP544738",
                "documentType": "contractNotice",
                "title": "BCU-CP-59436 - Detoxification Services",
                "description": "The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=SEP544738",
                "format": "text/html"
            },
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. Please see Information for Bidders document on the Bravo Solutions portal for further details. Betsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. The tender will be awarded based on 30% cost & 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered. The etenderwales bravosolution ref:Project: project_59436 and itt_120050 Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk.",
                "status": "active",
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 1080
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "an option to extend for two (2) further one (1) year periods, at the discretion of the Health Board and subject to supplier performance."
                }
            }
        ],
        "bidOpening": {
            "date": "2025-10-07T12:00:00Z"
        },
        "communication": {
            "atypicalToolUrl": "https://etenderwales.bravosolution.co.uk/web/login.shtml"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "submissionTerms": {
            "languages": [
                "en",
                "cy"
            ]
        },
        "classification": {
            "id": "85312500",
            "scheme": "CPV"
        },
        "hasRecurrence": true,
        "recurrence": {
            "description": "2028"
        },
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749 (WA Ref:155749) The buyer considers that this contract is suitable for consortia.",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-155749"
        }
    ],
    "noticetype": "OJEU - F2 - Contract Notice"
}